换一批
最新更新
1. Unlocking the promise of RAS inhibition in pancreatic cancer. 535-536页
作者：Saurav D,Haldar； Nilofer S,Azad
2. Viral hepatitis elimination - time to act. 529页
作者：
3. Fgfbp1<sup>+</sup> cells: upper crypt intestinal epithelial regeneration. 534页
作者：Jordan,Hindson
4. Endogenous ethanol production in health and disease. 556-571页
作者：Abraham S,Meijnikman； Max,Nieuwdorp； Bernd,Schnabl
5. A bloody disgrace - time to change patient safety culture. 530页
作者：Stuart,Cantrill
6. Neoadjuvant immunotherapy for mismatch repair-deficient colon cancer: a phase II study. 534页
作者：Jordan,Hindson
7. ETS2 regulates human inflammatory macrophages in IBD. 534页
作者：Katrina,Ray
8. Artificial intelligence in liver cancer - new tools for research and patient management. 585-599页
作者：Julien,Calderaro； Laura,Žigutytė； Daniel,Truhn； Ariel,Jaffe； Jakob Nikolas,Kather
9. Mother-to-child transmission of hepatitis B: current status and the road forward. 531-532页
作者：Yvonne A,Nartey； Ansumana S,Bockarie
10. Incretin-based therapies for liver disease. 533页
作者：Eleni,Kotsiliti
